MedPath

A Comparative Study to see the effect of Kokilaksha Tablet & Guduchi Tablet in the management of Gout

Phase 2
Conditions
Health Condition 1: M10- Gout
Registration Number
CTRI/2023/03/050927
Lead Sponsor
Dr Aarti Devkisan Gaikar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age limit from 18 to 70 years.

Patients having clinical symptoms of Vatarakta like joint pain, joint swelling, burning sensation, tenderness at joints, stiffness, local color changes in the skin.

Sr uric acid level â?? 2.5 â?? 12 mg/dl.

Exclusion Criteria

1) Patient with severe form of other systemic disorders like Cardiac disease, Renal failure, CVA etc.

2) Pregnant women and lactating mothers.

3) Injury requiring surgical interventions.

4) Any condition interfering the course of treatment.

5) Secondary hyperuricemia due to leukaemia, lymphoma, polycythaemia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in Pain.Timepoint: Baseline- 0 day,7 day,14 day.
Secondary Outcome Measures
NameTimeMethod
To observe the adverse effect, if any.Timepoint: 14 days study with follow up on 7th and 14th day.(0,7,14)
© Copyright 2025. All Rights Reserved by MedPath